条件を付加する。<br>(1) 分与希望者は事前に開発者 中木　敏夫（帝京大学）(nakaki@med.teikyo-u.ac.jp)に連絡をとり、分与に関して許可を得ること。（2）当該マウスを用いる論文発表に際してはAcc.No. CDB0590K、そのWEBサイト（www2.clst.riken.jp/arg/mutant%20mice%20list.html）とともに当該マウスを記載すること。（3）当該マウスを用いる論文発表に際しては、その由来として第一報論文 (Neurobiol Dis. 2012 45(3):973-982.) を引用すること。（4）発表論文を寄託者 (mutant.bdr@riken.jp) に連絡すること。 mouse GTRAP3-18, E. coli Neo, Phage P1 loxP, PGK promoter, mouse PGK3' end true D（6か月以上） TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] RBRC09338 GTRAP3-18(Acc.No.CDB0590K) GTRAP3-18(Acc.No.CDB0590K) (1) The RECIPIENT shall obtain a prior agreement from the DEVELOPER Dr. Toshio Nakaki (Teikyo University)(nakaki@med.teikyo-u.ac.jp) to transfer the BIOLOGICAL RESOURCE. (2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the Acc.No. CDB0590K and Web Site (www2.clst.riken.jp/arg/mutant%20mice%20list.html) is requested. (3) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designed by the DEPOSITOR is requested (Neurobiol Dis. 2012 45(3):973-982.). (4) Please inform the DEPOSITOR (mutant.bdr@riken.jp) about the paper when published. RIKEN CDB RIKEN CDB D (more than 6 months) Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol>